New registry monitors VBX stent graft in Real-World use

NCT ID NCT03720704

Ongoing Knowledge-focused Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that collects safety and performance data on the GORE® VIABAHN® VBX Stent Graft when used in peripheral vessels. It involves 280 adults who need this device to treat peripheral vascular disease. The goal is to see how well the stent graft works and if there are any serious side effects within 30 days of the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL VASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral vascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL VASCULAR DISEASES

Contacts and locations

Locations

Azienda Ospedaliera Policlinico Sant'Orsola Malpighi

Bologna, Italy
Azienda Ospedaliero-Universitaria di Padova

Padova, Italy
Erasmus Medical Center

Rotterdam, Netherlands
Fondazione Poliambulanza

Brescia, Italy
Hospital Universitario Central de Asturias (HUCA)

Oviedo, Spain
Hôpital Marie Lannelongue

Paris, France
Ospedale di Circolo e Fondazione Macchi

Varese, Italy
St. Franziskus Hospital

Münster, Germany
University Hospital Heidelberg

Heidelberg, Germany
University Hospital of Santiago de Compostela

Santiago de Compostela, Spain
University Medical Center Groningen

Groningen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.